ANIK
Anika Therapeutics, Inc.
Company overview
- Market capitalization
- $276.76M
- Employees
- 235
- Latest publication
- 2026-09-29
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation. It also provides Integrity, an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; non-orthopedic products, including Hyvisc, a high molecular weight injectable HA veterinary product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine OA; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and ophthalmic products; and Anikavisc and Nuvisc high molecular weight HA products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20212021-09-30 · USD | Q2 20212021-06-30 · USD | Q1 20212021-03-31 · USD | Q1 20202020-03-31 · USD | Q4 20192019-12-31 · USD | Q3 20192019-09-30 · USD | Q2 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 32,610,000USD | 39,536,000USD | 38,145,000USD | 34,292,000USD | 35,397,000USD | 29,772,000USD | 29,697,000USD | 30,418,000USD |
| Cost Of Revenue | 11,366,000USD | 16,513,000USD | 17,333,000USD | 13,318,000USD | 14,200,000USD | 8,649,000USD | 5,951,000USD | 6,836,000USD |
| Gross Profit | 21,244,000USD | 23,023,000USD | 20,812,000USD | 20,974,000USD | 21,197,000USD | 21,123,000USD | 23,746,000USD | 23,582,000USD |
| Research Development | 7,341,000USD | 7,673,000USD | 7,293,000USD | 6,361,000USD | 6,050,000USD | 4,084,000USD | 4,158,000USD | 4,165,000USD |
| Selling General Administrative | 10,949,000USD | 14,050,000USD | 17,989,000USD | 15,179,000USD | 14,431,000USD | 12,237,000USD | 7,539,000USD | 7,502,000USD |
| Total Operating Expenses | 18,290,000USD | 21,723,000USD | 11,632,000USD | 19,716,000USD | 14,103,000USD | 16,321,000USD | 11,697,000USD | 11,667,000USD |
| Operating Income | 2,954,000USD | 1,300,000USD | 9,180,000USD | 1,258,000USD | 7,094,000USD | 4,802,000USD | 12,049,000USD | 11,915,000USD |
| Total Other Income Expense Net | 426,000USD | -48,000USD | -50,000USD | -43,000USD | 279,000USD | 360,000USD | 482,000USD | 533,000USD |
| Income Before Tax | 3,380,000USD | 1,252,000USD | 9,130,000USD | 1,215,000USD | 7,373,000USD | 5,162,000USD | 12,531,000USD | 12,448,000USD |
| Income Tax Expense | 71,000USD | 694,000USD | 2,599,000USD | -1,623,000USD | 1,580,000USD | 1,111,000USD | 3,331,000USD | 3,013,000USD |
| Discontinued Operations | 0USD | — | — | — | — | — | — | — |
| Net Income | 3,309,000USD | 558,000USD | 6,531,000USD | 2,838,000USD | 5,793,000USD | 4,051,000USD | 9,200,000USD | 9,435,000USD |
| Interest Expense | — | 48,000USD | 50,000USD | 43,000USD | 279,000USD | 360,000USD | 482,000USD | 533,000USD |
| Net Interest Income | — | -48,000USD | -50,000USD | -43,000USD | 279,000USD | 360,000USD | 482,000USD | 533,000USD |
| Tax Provision | — | 694,000USD | 2,599,000USD | -1,623,000USD | 1,580,000USD | 1,111,000USD | 3,331,000USD | 3,013,000USD |
| Net Income From Continuing Ops | — | 558,000USD | 6,531,000USD | 2,838,000USD | 5,793,000USD | 4,051,000USD | 9,200,000USD | 9,435,000USD |
| Ebit | — | -2,150,000USD | -4,470,000USD | -3,562,000USD | 716,000USD | 4,802,000USD | 12,049,000USD | 12,448,000USD |
| Ebitda | — | 1,426,000USD | -967,000USD | -54,000USD | 3,477,000USD | 6,334,000USD | 13,565,000USD | 13,617,000USD |
| Depreciation And Amortization | — | 3,576,000USD | 3,503,000USD | 3,508,000USD | 2,761,000USD | 1,532,000USD | 1,516,000USD | 1,169,000USD |
| Reconciled Depreciation | — | 3,576,000USD | 3,503,000USD | 3,508,000USD | 2,761,000USD | 1,532,000USD | 1,516,000USD | 1,169,000USD |
| Net Income Applicable To Common Shares | — | 558,000USD | 6,531,000USD | 2,838,000USD | 5,793,000USD | 4,051,000USD | 9,200,000USD | 9,435,000USD |
| Unclassified Operating Expenses | — | — | -13,650,000USD | -1,824,000USD | -6,378,000USD | — | — | — |
| Interest Income | — | — | — | — | 279,000USD | 360,000USD | 482,000USD | 533,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20212021-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 147,794,000USD | 114,610,000USD | 105,555,000USD | 113,420,000USD | 103,379,000USD | 92,999,000USD | 105,594,839USD | 75,081,154USD |
| Cost Of Revenue | 64,851,000USD | 28,747,000USD | 31,280,000USD | 27,364,000USD | 24,027,000USD | 21,053,000USD | 20,930,318USD | 22,765,404USD |
| Gross Profit | 82,943,000USD | 85,863,000USD | 74,275,000USD | 86,056,000USD | 79,352,000USD | 71,946,000USD | 84,664,521USD | 52,315,750USD |
| Research Development | 27,327,000USD | 16,665,000USD | 18,190,000USD | 18,787,000USD | 10,732,000USD | 8,987,000USD | 8,144,152USD | 7,059,875USD |
| Selling General Administrative | 53,001,000USD | 34,950,000USD | 34,336,000USD | 21,540,000USD | 18,013,000USD | 14,825,000USD | 15,073,485USD | 12,936,000USD |
| Total Operating Expenses | 80,328,000USD | 51,615,000USD | 52,526,000USD | 40,327,000USD | 28,745,000USD | 23,812,000USD | 23,217,637USD | 19,995,876USD |
| Operating Income | 2,615,000USD | 34,248,000USD | 21,749,000USD | 45,729,000USD | 50,607,000USD | 48,134,000USD | 61,446,884USD | 32,606,717USD |
| Interest Expense | 188,000USD | 7,864,000USD | 1,458,000USD | 473,000USD | 263,000USD | 120,000USD | 58,137USD | 127,186USD |
| Net Interest Income | -188,000USD | 1,873,000USD | 1,458,000USD | 473,000USD | 263,000USD | — | — | — |
| Income Before Tax | 2,427,000USD | 36,121,000USD | 23,207,000USD | 46,202,000USD | 50,870,000USD | 48,254,000USD | 61,505,021USD | 32,479,531USD |
| Income Tax Expense | -1,707,000USD | 8,928,000USD | 4,485,000USD | 14,386,000USD | 18,323,000USD | 17,496,000USD | 23,185,542USD | 11,905,010USD |
| Tax Provision | -1,707,000USD | 8,928,000USD | 4,485,000USD | 14,386,000USD | 18,323,000USD | 17,496,000USD | — | — |
| Net Income | 4,134,000USD | 27,193,000USD | 18,722,000USD | 31,816,000USD | 32,547,000USD | 30,758,000USD | 38,319,479USD | 20,574,521USD |
| Net Income From Continuing Ops | 4,134,000USD | 27,193,000USD | 18,722,000USD | 31,816,000USD | 32,547,000USD | 30,758,000USD | 38,319,479USD | 20,574,521USD |
| Ebit | -18,480,000USD | 34,248,000USD | 21,749,000USD | 45,729,000USD | 50,607,000USD | 48,134,000USD | 61,446,884USD | 27,260,540USD |
| Ebitda | -4,163,000USD | 40,239,000USD | 27,659,000USD | 50,019,000USD | 54,341,000USD | 51,909,000USD | 66,152,486USD | 32,033,031USD |
| Depreciation And Amortization | 14,317,000USD | 5,991,000USD | 5,910,000USD | 4,290,000USD | 3,734,000USD | 3,775,000USD | 4,705,602USD | 4,772,491USD |
| Reconciled Depreciation | 14,317,000USD | 5,991,000USD | 5,910,000USD | 4,290,000USD | — | — | — | — |
| Total Other Income Expense Net | -188,000USD | 1,873,000USD | 1,458,000USD | 473,000USD | 263,000USD | 120,000USD | 58,137USD | -127,000USD |
| Net Income Applicable To Common Shares | 4,134,000USD | 27,193,000USD | 18,722,000USD | 31,816,000USD | 32,547,000USD | 30,758,000USD | 38,319,479USD | 20,575,000USD |
| Interest Income | — | 1,873,000USD | 1,458,000USD | 473,000USD | 263,000USD | 120,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 183,474,000USD | 179,387,000USD | 190,270,000USD | 189,437,000USD | 187,682,000USD | 190,605,000USD | 202,740,000USD | 231,405,000USD |
| Cash And Equivalents | 38,412,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 99,190,000USD | 93,561,000USD | 103,358,000USD | 101,590,000USD | 99,317,000USD | 102,509,000USD | 113,652,000USD | 136,106,000USD |
| Other Current Assets | 3,151,000USD | 3,935,000USD | 3,400,000USD | 5,129,000USD | 5,273,000USD | 5,815,000USD | 10,620,000USD | 5,752,000USD |
| Other Non Current Assets | 3,023,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 46,192,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 22,147,000USD | 20,966,000USD | 21,908,000USD | 19,089,000USD | 16,081,000USD | 17,901,000USD | 23,306,000USD | 25,493,000USD |
| Other Non Current Liabilities | 730,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 137,282,000USD | 133,901,000USD | 143,465,000USD | 146,805,000USD | 147,672,000USD | 148,397,000USD | 153,989,000USD | 179,864,000USD |
| Total Equity Including Noncontrolling Interest | 137,282,000USD | — | — | — | — | — | — | — |
| Net Receivables | 29,062,000USD | 25,768,000USD | 23,690,000USD | 22,187,000USD | 23,955,000USD | 21,987,000USD | 23,594,000USD | 28,357,000USD |
| Inventory | 28,565,000USD | 22,838,000USD | 18,787,000USD | 16,283,999USD | 16,922,000USD | 21,336,000USD | 23,809,000USD | 39,629,000USD |
| Property Plant Equipment Net | 65,051,000USD | 65,152,000USD | 66,263,000USD | 64,910,000USD | 65,805,000USD | 65,641,000USD | 64,679,000USD | 71,780,000USD |
| Goodwill | 7,825,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 1,650,000USD | 1,650,000USD | 1,650,000USD | 1,650,000USD | 1,661,000USD | 2,281,000USD | 2,490,000USD | 3,081,000USD |
| Accounts Payable | 6,236,000USD | 6,339,000USD | 6,041,000USD | 4,732,000USD | 4,771,000USD | 5,277,000USD | 5,617,000USD | 6,805,000USD |
| Common Stock | 134,000USD | 133,000USD | 139,000USD | 144,000USD | 144,000USD | 143,000USD | 144,000USD | 147,000USD |
| Retained Earnings | 59,040,000USD | 55,731,000USD | 60,787,000USD | 60,495,000USD | 62,824,000USD | 66,794,000USD | 71,667,000USD | 93,532,000USD |
| Accumulated Other Comprehensive Income | -5,329,000USD | -5,310,000USD | -4,959,000USD | -4,939,000USD | -4,755,000USD | -6,103,000USD | -6,783,000USD | -5,701,000USD |
| Total Liab | — | 45,486,000USD | 46,805,000USD | 42,632,000USD | 40,010,000USD | 42,208,000USD | 48,751,000USD | 51,541,000USD |
| Other Current Liab | — | 12,456,000USD | 13,815,000USD | 12,632,000USD | 9,495,000USD | 10,685,000USD | 15,708,000USD | 16,314,000USD |
| Capital Stock | — | 133,000USD | 139,000USD | 144,000USD | 144,000USD | 143,000USD | 144,000USD | 147,000USD |
| Good Will | — | 7,892,000USD | 8,054,000USD | 8,051,000USD | 8,056,000USD | 7,423,000USD | 7,125,000USD | 7,656,000USD |
| Cash | — | 41,020,000USD | 57,481,000USD | 57,990,000USD | 53,167,000USD | 53,371,000USD | 55,629,000USD | 62,368,000USD |
| Cash And Short Term Investments | — | 41,020,000USD | 57,481,000USD | 57,990,000USD | 53,167,000USD | 53,371,000USD | 55,629,000USD | 62,368,000USD |
| Current Deferred Revenue | — | 229,000USD | — | — | — | — | — | -2,292,000USD |
| Net Debt | — | -15,284,000USD | -31,233,000USD | -33,483,000USD | -28,179,000USD | -27,934,000USD | -29,697,000USD | -34,834,000USD |
| Short Term Debt | — | 1,942,000USD | 2,052,000USD | 1,725,000USD | 1,815,000USD | 1,874,000USD | 1,918,000USD | 2,292,000USD |
| Short Long Term Debt Total | — | 25,736,000USD | 26,248,000USD | 24,507,000USD | 24,988,000USD | 25,437,000USD | 25,932,000USD | 27,534,000USD |
| Property Plant Equipment Gross | — | 117,905,000USD | 117,691,000USD | 115,476,000USD | 115,010,000USD | 113,287,000USD | 110,963,000USD | 71,780,000USD |
| Common Stock Shares Outstanding | — | 13,531,000shares | 14,669,000shares | 14,419,000shares | 14,364,000shares | 14,297,000shares | 14,721,000shares | 14,768,000shares |
| Non Current Assets Total | — | 85,826,000USD | 86,912,000USD | 87,847,000USD | 88,365,000USD | 88,096,000USD | 89,088,000USD | 95,299,000USD |
| Non Current Liabilities Total | — | 24,519,999USD | 24,897,000USD | 23,543,000USD | 23,929,000USD | 24,307,000USD | 25,445,000USD | 26,048,000USD |
| Non Current Liabilities Other | — | 726,000USD | 701,000USD | 761,000USD | 756,000USD | 744,000USD | 772,000USD | 806,000USD |
| Non Currrent Assets Other | — | 4,303,000USD | 9,670,000USD | 5,507,000USD | 11,589,000USD | 11,563,000USD | 13,617,000USD | 11,310,000USD |
| Net Working Capital | — | 72,595,000USD | 81,450,000USD | 82,501,000USD | 83,236,000USD | 84,608,000USD | 90,346,000USD | 110,613,000USD |
| Unclassified Non Current Assets | — | 6,829,000USD | 1,275,000USD | 7,729,000USD | 1,254,000USD | 1,188,000USD | 1,177,000USD | 1,472,000USD |
| Unclassified Non Current Liabilities | — | 23,793,999USD | 24,196,000USD | 22,782,000USD | 23,173,000USD | 23,563,000USD | 24,673,000USD | 25,242,000USD |
| Unclassified Equity | — | 83,214,000USD | 87,359,000USD | 90,961,000USD | 89,315,000USD | 87,420,000USD | 88,817,000USD | 91,739,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 190,270,000USD | 202,740,000USD | 270,632,000USD | 349,128,000USD | 347,535,000USD | 365,605,000USD | 330,710,000USD | 278,993,000USD |
| Intangible Assets | 1,650,000USD | 2,490,000USD | 2,576,000USD | 74,599,000USD | 82,382,000USD | 91,157,000USD | 7,585,000USD | 9,191,000USD |
| Other Current Assets | 3,400,000USD | 10,620,000USD | 43,781,000USD | 8,828,000USD | 8,289,000USD | 8,754,000USD | 4,289,000USD | 1,854,000USD |
| Total Liab | 46,805,000USD | 48,751,000USD | 58,367,000USD | 63,565,000USD | 60,450,000USD | 93,205,000USD | 42,332,000USD | 15,381,000USD |
| Total Stockholder Equity | 143,465,000USD | 153,989,000USD | 212,265,000USD | 285,563,000USD | 287,085,000USD | 272,400,000USD | 288,378,000USD | 263,612,000USD |
| Other Current Liab | 13,815,000USD | 15,708,000USD | 21,798,000USD | 15,957,000USD | 20,448,000USD | 26,298,000USD | 11,304,000USD | 7,761,000USD |
| Common Stock | 139,000USD | 144,000USD | 147,000USD | 146,000USD | 144,000USD | 143,000USD | 143,000USD | 142,000USD |
| Capital Stock | 139,000USD | 144,000USD | 147,000USD | 146,000USD | 144,000USD | 143,000USD | 143,000USD | 142,000USD |
| Retained Earnings | 60,787,000USD | 71,667,000USD | 128,052,000USD | 210,719,000USD | 225,578,000USD | 221,444,000USD | 245,426,000USD | 218,233,000USD |
| Good Will | 8,054,000USD | 7,125,000USD | 7,571,000USD | 7,339,000USD | 7,781,000USD | 8,413,000USD | 7,694,000USD | 7,851,000USD |
| Cash | 57,481,000USD | 55,629,000USD | 68,740,000USD | 86,327,000USD | 94,386,000USD | 95,817,000USD | 157,463,000USD | 89,042,000USD |
| Cash And Short Term Investments | 57,481,000USD | 55,629,000USD | 68,740,000USD | 86,327,000USD | 94,386,000USD | 98,318,000USD | 184,943,000USD | 159,014,000USD |
| Total Current Assets | 103,358,000USD | 113,652,000USD | 163,309,000USD | 169,547,000USD | 168,528,000USD | 177,383,000USD | 234,306,000USD | 202,943,000USD |
| Total Current Liabilities | 21,908,000USD | 23,306,000USD | 31,059,000USD | 27,914,000USD | 29,795,000USD | 36,867,000USD | 16,277,000USD | 11,289,000USD |
| Net Debt | -31,233,000USD | -29,697,000USD | -40,998,000USD | -55,437,000USD | -73,432,000USD | -73,353,000USD | -134,955,000USD | -89,042,000USD |
| Short Term Debt | 2,052,000USD | 1,918,000USD | 1,827,000USD | 2,073,000USD | 1,714,000USD | 1,585,000USD | 1,141,000USD | — |
| Short Long Term Debt Total | 26,248,000USD | 25,932,000USD | 27,742,000USD | 30,890,000USD | 20,954,000USD | 22,464,000USD | 22,508,000USD | — |
| Net Receivables | 23,690,000USD | 23,594,000USD | 26,360,000USD | 34,627,000USD | 29,843,000USD | 24,102,000USD | 23,079,000USD | 20,775,000USD |
| Inventory | 18,787,000USD | 23,809,000USD | 24,428,000USD | 39,765,000USD | 36,010,000USD | 46,209,000USD | 21,995,000USD | 21,300,000USD |
| Accounts Payable | 6,041,000USD | 5,617,000USD | 6,194,000USD | 9,074,000USD | 7,633,000USD | 8,984,000USD | 3,832,000USD | 3,143,000USD |
| Property Plant Equipment Net | 66,263,000USD | 64,679,000USD | 64,999,000USD | 78,975,000USD | 68,559,000USD | 73,232,000USD | 73,647,000USD | 54,111,000USD |
| Property Plant Equipment Gross | 117,691,000USD | 110,963,000USD | 122,634,000USD | 48,279,000USD | 47,602,000USD | 73,232,000USD | 73,647,000USD | 54,111,000USD |
| Accumulated Other Comprehensive Income | -4,959,000USD | -6,783,000USD | -5,943,000USD | -6,443,000USD | -5,718,000USD | -4,542,000USD | -5,898,000USD | -5,526,000USD |
| Common Stock Shares Outstanding | 14,339,000shares | 14,721,000shares | 14,656,000shares | 14,561,000shares | 14,634,000shares | 14,222,163shares | 14,374,000shares | 14,689,000shares |
| Non Current Assets Total | 86,912,000USD | 89,088,000USD | 107,323,000USD | 179,581,000USD | 179,007,000USD | 188,222,000USD | 96,404,000USD | 76,050,000USD |
| Non Current Liabilities Total | 24,897,000USD | 25,445,000USD | 27,308,000USD | 35,651,000USD | 30,655,000USD | 56,338,000USD | 26,055,000USD | 4,092,000USD |
| Non Current Liabilities Other | 701,000USD | 772,000USD | 404,000USD | 398,000USD | 1,258,000USD | 23,564,000USD | 357,000USD | 550,000USD |
| Non Currrent Assets Other | 9,670,000USD | 13,617,000USD | 30,688,000USD | 17,219,000USD | 20,285,000USD | 15,420,000USD | 7,478,000USD | 4,897,000USD |
| Net Working Capital | 81,450,000USD | 90,346,000USD | 132,250,000USD | 141,633,000USD | 138,733,000USD | 140,516,000USD | 218,029,000USD | 195,487,000USD |
| Unclassified Non Current Assets | 1,275,000USD | 1,177,000USD | 1,489,000USD | -17,219,000USD | -20,285,000USD | -38,039,000USD | — | -4,897,000USD |
| Unclassified Non Current Liabilities | 24,196,000USD | 24,673,000USD | 26,904,000USD | 21,983,000USD | 7,825,000USD | -14,580,000USD | 16,679,000USD | -4,092,000USD |
| Unclassified Equity | 87,359,000USD | 88,817,000USD | 89,862,000USD | 80,995,000USD | 66,937,000USD | 55,212,000USD | 48,564,000USD | 50,621,000USD |
| Current Deferred Revenue | — | — | 1,240,000USD | — | 16,133,000USD | 13,208,000USD | — | — |
| Deferred Long Term Liab | — | — | — | 6,436,000USD | 10,157,000USD | 11,895,000USD | 4,331,000USD | 3,542,000USD |
| Other Liab | — | — | — | 6,834,000USD | 11,415,000USD | 35,459,000USD | 4,688,000USD | 4,092,000USD |
| Other Assets | — | — | — | 18,668,000USD | 20,285,000USD | 38,039,000USD | -1,441,000USD | 4,897,000USD |
| Short Term Investments | — | — | — | 34,627,000USD | — | 2,501,000USD | 27,480,000USD | 69,972,000USD |
| Net Tangible Assets | — | — | — | 232,442,000USD | 216,162,000USD | 193,709,000USD | 294,466,000USD | 263,612,000USD |
| Unclassified Current Assets | — | — | — | -34,627,000USD | — | — | — | — |
| Unclassified Current Liabilities | — | — | — | — | -16,133,000USD | -13,208,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,056,000USD | 292,000USD | -2,329,000USD | -3,970,000USD | -4,873,000USD | -21,865,000USD | -29,918,000USD | -88,000USD |
| Depreciation | 1,407,000USD | 1,318,000USD | 1,403,000USD | 1,416,000USD | 1,592,000USD | 1,812,000USD | 2,188,000USD | 2,058,000USD |
| Stock Based Compensation | 6,641,000USD | 2,458,000USD | 2,215,000USD | 2,548,000USD | 2,863,000USD | 2,255,000USD | 3,394,000USD | 3,891,000USD |
| Other Non Cash Items | 1,241,000USD | 1,725,000USD | 1,168,000USD | 3,653,000USD | 539,000USD | 21,509,000USD | 28,044,000USD | 1,095,000USD |
| Change To Account Receivables | -2,180,000USD | -1,545,000USD | 1,294,000USD | -2,375,000USD | 3,034,000USD | -3,272,000USD | 4,779,000USD | -1,765,000USD |
| Change To Inventory | -5,407,000USD | -1,779,000USD | -443,000USD | 1,729,000USD | 523,000USD | 2,391,000USD | -3,003,000USD | -4,722,000USD |
| Change In Working Capital | -9,187,000USD | -1,131,000USD | 4,410,000USD | -3,833,000USD | -269,000USD | -2,363,000USD | 1,492,000USD | -8,042,000USD |
| Total Cash From Operating Activities | -4,846,000USD | 4,637,000USD | 6,870,000USD | -189,000USD | -130,000USD | 1,582,000USD | 5,016,000USD | -1,069,000USD |
| Capital Expenditures | -1,431,000USD | -648,000USD | -1,887,000USD | -1,467,000USD | -2,824,000USD | -1,307,000USD | -1,816,000USD | -3,403,000USD |
| Free Cash Flow | -6,277,000USD | 3,989,000USD | 4,983,000USD | -1,656,000USD | -2,954,000USD | 275,000USD | 3,200,000USD | -4,472,000USD |
| Total Cashflows From Investing Activities | -1,239,000USD | 198,000USD | -1,732,000USD | -539,000USD | 1,672,000USD | -1,307,000USD | -1,816,000USD | -3,403,000USD |
| Total Cash From Financing Activities | -10,347,000USD | -5,279,000USD | -13,000USD | 179,000USD | -5,438,000USD | -5,354,000USD | -3,991,000USD | -1,111,000USD |
| Sale Purchase Of Stock | -8,690,000USD | -5,514,000USD | -13,000USD | 0USD | -3,971,000USD | -5,575,000USD | -3,969,000USD | -1,370,000USD |
| Change In Cash | -16,461,000USD | -509,000USD | 4,823,000USD | -204,000USD | -3,788,000USD | -5,209,000USD | -454,000USD | -5,807,000USD |
| Begin Period Cash Flow | 57,481,000USD | 57,990,000USD | 53,167,000USD | 53,371,000USD | 57,159,000USD | 62,368,000USD | 62,822,000USD | 68,629,000USD |
| End Period Cash Flow | 41,020,000USD | 57,481,000USD | 57,990,000USD | 53,167,000USD | 53,371,000USD | 57,159,000USD | 62,368,000USD | 62,822,000USD |
| Other Cashflows From Investing Activities | 192,000USD | -3,650,000USD | 155,000USD | 928,000USD | 4,496,000USD | — | -600,000USD | — |
| Other Cashflows From Financing Activities | -1,657,000USD | -4,000USD | -13,000USD | -82,000USD | -1,467,000USD | 221,000USD | -22,000USD | -205,000USD |
| Unclassified Investing Cash Flow | — | 4,496,000USD | 1,732,000USD | — | -1,672,000USD | 1,307,000USD | 2,416,000USD | 3,403,000USD |
| Investments | — | — | -1,732,000USD | -539,000USD | 1,672,000USD | -1,307,000USD | -1,816,000USD | -3,403,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,880,000USD | -56,385,000USD | -82,667,000USD | -14,859,000USD | 4,134,000USD | -23,982,000USD | 27,193,000USD | 18,722,000USD |
| Depreciation | 5,729,000USD | 8,121,000USD | 14,217,000USD | 14,487,000USD | 14,317,000USD | 14,995,000USD | 5,991,000USD | 5,910,000USD |
| Stock Based Compensation | 10,084,000USD | 13,130,000USD | 15,243,000USD | 14,315,000USD | 11,085,000USD | 5,386,000USD | 6,087,000USD | 11,046,000USD |
| Other Non Cash Items | 7,085,000USD | 53,369,000USD | 69,869,000USD | 7,557,000USD | -4,655,000USD | 39,053,000USD | 3,583,000USD | 4,257,000USD |
| Change To Account Receivables | 408,000USD | 3,366,000USD | -1,305,000USD | -5,630,000USD | -6,216,000USD | 5,855,000USD | -1,839,000USD | 2,914,000USD |
| Change To Inventory | 30,000USD | -9,424,000USD | -11,396,000USD | -6,873,000USD | -6,619,000USD | -14,177,000USD | -5,585,000USD | -7,577,000USD |
| Change In Working Capital | -823,000USD | -13,092,000USD | -12,123,000USD | -11,821,000USD | -14,718,000USD | -13,458,000USD | -6,643,000USD | -3,200,000USD |
| Total Cash From Operating Activities | 11,188,000USD | 5,403,000USD | -1,788,000USD | 4,409,000USD | 8,397,000USD | 13,065,000USD | 37,005,000USD | 34,918,000USD |
| Capital Expenditures | -6,826,000USD | -7,734,000USD | -5,427,000USD | -7,486,000USD | -5,143,000USD | -1,628,000USD | -2,827,000USD | -4,656,000USD |
| Free Cash Flow | 4,362,000USD | -2,331,000USD | -7,215,000USD | -3,077,000USD | 3,254,000USD | 11,437,000USD | 34,178,000USD | 30,262,000USD |
| Total Cashflows From Investing Activities | -401,000USD | -8,334,000USD | -5,427,000USD | -7,486,000USD | -3,118,000USD | -71,264,000USD | 39,691,000USD | -50,257,000USD |
| Total Cash From Financing Activities | -10,551,000USD | -12,729,000USD | -6,324,000USD | -4,852,000USD | -6,779,000USD | -3,774,000USD | -8,142,000USD | -28,904,000USD |
| Sale Purchase Of Stock | -9,485,000USD | -10,914,000USD | -5,000,000USD | -934,000USD | -486,000USD | -262,000USD | -30,000,000USD | -30,000,000USD |
| Change In Cash | 322,000USD | -15,708,000USD | -13,460,000USD | -8,059,000USD | -1,431,000USD | -61,646,000USD | 68,421,000USD | -44,214,000USD |
| Begin Period Cash Flow | 57,159,000USD | 72,867,000USD | 86,327,000USD | 94,386,000USD | 95,817,000USD | 157,463,000USD | 89,042,000USD | 133,256,000USD |
| End Period Cash Flow | 57,481,000USD | 57,159,000USD | 72,867,000USD | 86,327,000USD | 94,386,000USD | 95,817,000USD | 157,463,000USD | 89,042,000USD |
| Other Cashflows From Investing Activities | -2,567,000USD | -600,000USD | — | -7,486,000USD | 2,025,000USD | 24,965,000USD | 42,518,000USD | -45,601,000USD |
| Other Cashflows From Financing Activities | -1,566,000USD | -1,815,000USD | -1,324,000USD | -5,249,000USD | -7,706,000USD | -4,739,999USD | 21,858,000USD | 1,096,000USD |
| Unclassified Investing Cash Flow | 8,992,000USD | 8,334,000USD | 6,116,000USD | 14,972,000USD | -2,501,000USD | -119,566,000USD | -42,518,000USD | 45,601,000USD |
| Investments | — | -8,334,000USD | -6,116,000USD | -7,486,000USD | 2,501,000USD | 24,965,000USD | 42,518,000USD | -45,601,000USD |
| Net Borrowings | — | 0USD | 0USD | -284,000USD | -201,000USD | -350,000USD | -558,000USD | -558,000USD |
| Unclassified Operating Cash Flow | — | — | -6,327,000USD | -5,270,000USD | -1,766,000USD | -8,929,000USD | — | -1,817,000USD |
| Change To Liabilities | — | — | — | 2,959,000USD | 1,099,000USD | -1,392,000USD | 3,487,000USD | 564,000USD |
| Dividends Paid | — | — | — | -253,000USD | -642,000USD | -1,262,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -7,929,000USD | -1,500,000USD | -61,973,000USD | 68,421,000USD | -44,214,000USD |
| Unclassified Financing Cash Flow | — | — | — | 1,868,000USD | 2,256,000USD | 2,839,999USD | — | — |
| Exchange Rate Changes | — | — | — | — | — | — | -133,000USD | 29,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Europe | 6,836,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Other Location | 5,970,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 19,804,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Commercial Channel | 13,905,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | OEMChannel | 18,705,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Europe | 6,666,000 | USD | 0001171843-26-002852 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Other Location | 4,446,000 | USD | 0001171843-26-002852 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 18,500,000 | USD | 0001171843-26-002852 |
| Q1 2026Quarterly · 2026-03-31 | Product | Commercial Channel | 12,577,000 | USD | 0001171843-26-002852 |
| Q1 2026Quarterly · 2026-03-31 | Product | OEMChannel | 17,035,000 | USD | 0001171843-26-002852 |
| Q4 2025Quarterly · 2025-12-31 | Geography | Europe | 5,996,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | Other Location | 6,294,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 18,330,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Commercial Channel | 13,302,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | OEMChannel | 17,313,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Europe | 22,214,000 | USD | 0001171843-26-001275 |
| FY 2025Yearly · 2025-12-31 | Geography | Other Location | 20,547,000 | USD | 0001171843-26-001275 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 70,100,000 | USD | 0001171843-26-001275 |
| FY 2025Yearly · 2025-12-31 | Product | Commercial Channel | 48,413,000 | USD | 0001171843-26-001275 |
| FY 2025Yearly · 2025-12-31 | Product | OEMChannel | 64,406,000 | USD | 0001171843-26-001275 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Europe | 5,668,000 | USD | 0001171843-25-007032 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Other Location | 4,703,000 | USD | 0001171843-25-007032 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 17,446,000 | USD | 0001171843-25-007032 |
| Q3 2025Quarterly · 2025-09-30 | Product | Commercial Channel | 11,973,000 | USD | 0001171843-25-007032 |
| Q3 2025Quarterly · 2025-09-30 | Product | OEMChannel | 15,844,000 | USD | 0001171843-25-007032 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Europe | 4,752,000 | USD | 0001171843-25-004826 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Other Location | 5,543,000 | USD | 0001171843-25-004826 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 17,924,000 | USD | 0001171843-25-004826 |
| Q2 2025Quarterly · 2025-06-30 | Product | Commercial Channel | 11,879,000 | USD | 0001171843-25-004826 |
| Q2 2025Quarterly · 2025-06-30 | Product | OEMChannel | 16,340,000 | USD | 0001171843-25-004826 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Europe | 5,798,000 | USD | 0001171843-26-002852 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Other Location | 4,007,000 | USD | 0001171843-26-002852 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 16,400,000 | USD | 0001171843-26-002852 |
| Q1 2025Quarterly · 2025-03-31 | Product | Commercial Channel | 11,259,000 | USD | 0001171843-26-002852 |
| Q1 2025Quarterly · 2025-03-31 | Product | OEMChannel | 14,909,000 | USD | 0001171843-26-002852 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Europe | 4,330,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Other Location | 4,877,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 21,321,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Commercial Channel | 10,933,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | OEMChannel | 19,669,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Europe | 19,403,000 | USD | 0001171843-26-001275 |
| FY 2024Yearly · 2024-12-31 | Geography | Other Location | 18,058,000 | USD | 0001171843-26-001275 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 82,400,000 | USD | 0001171843-26-001275 |
| FY 2024Yearly · 2024-12-31 | Product | Commercial Channel | 42,137,000 | USD | 0001171843-26-001275 |
| FY 2024Yearly · 2024-12-31 | Product | OEMChannel | 77,770,000 | USD | 0001171843-26-001275 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Europe | 4,795,000 | USD | 0001171843-25-007032 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Other Location | 4,175,000 | USD | 0001171843-25-007032 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 20,589,000 | USD | 0001171843-25-007032 |
| Q3 2024Quarterly · 2024-09-30 | Product | Commercial Channel | 9,795,000 | USD | 0001171843-25-007032 |
| Q3 2024Quarterly · 2024-09-30 | Product | OEMChannel | 19,764,000 | USD | 0001171843-25-007032 |
| FY 2023Yearly · 2023-12-31 | Geography | Europe | 17,313,000 | USD | 0001171843-26-001275 |
| FY 2023Yearly · 2023-12-31 | Geography | Other Location | 16,568,000 | USD | 0001171843-26-001275 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 86,900,000 | USD | 0001171843-26-001275 |
| FY 2023Yearly · 2023-12-31 | Product | Commercial Channel | 36,147,000 | USD | 0001171843-26-001275 |
| FY 2023Yearly · 2023-12-31 | Product | OEMChannel | 84,645,000 | USD | 0001171843-26-001275 |
| FY 2022Yearly · 2022-12-31 | Geography | Europe | 17,227,000 | USD | 0001171843-25-001486 |
| FY 2022Yearly · 2022-12-31 | Geography | Other Location | 12,854,000 | USD | 0001171843-25-001486 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 83,700,000 | USD | 0001171843-25-001486 |
| FY 2022Yearly · 2022-12-31 | Product | Commercial Channel | 32,152,000 | USD | 0001171843-25-001486 |
| FY 2022Yearly · 2022-12-31 | Product | OEMChannel | 81,675,000 | USD | 0001171843-25-001486 |
| FY 2021Yearly · 2021-12-31 | Geography | Europe | 19,580,000 | USD | 0001171843-24-001380 |
| FY 2021Yearly · 2021-12-31 | Geography | Other Location | 14,381,000 | USD | 0001171843-24-001380 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 113,833,000 | USD | 0001171843-24-001380 |
| FY 2021Yearly · 2021-12-31 | Product | Joint Preservation And Restoration | 48,588,000 | USD | 0001171843-22-001790 |
| FY 2021Yearly · 2021-12-31 | Product | Licensing Milestone And Contract Revenue | 0 | USD | 0001171843-22-001790 |
| FY 2021Yearly · 2021-12-31 | Product | Nonorthopedic | 9,703,000 | USD | 0001171843-22-001790 |
| FY 2021Yearly · 2021-12-31 | Product | OAPain Management | 89,503,000 | USD | 0001171843-22-001790 |
| FY 2020Yearly · 2020-12-31 | Geography | Europe | 14,179,000 | USD | 0001171843-23-001729 |
| FY 2020Yearly · 2020-12-31 | Geography | Other Location | 13,096,000 | USD | 0001171843-23-001729 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 103,182,000 | USD | 0001171843-23-001729 |
| FY 2020Yearly · 2020-12-31 | Product | Joint Preservation And Restoration | 39,368,000 | USD | 0001171843-22-001790 |
| FY 2020Yearly · 2020-12-31 | Product | Licensing Milestone And Contract Revenue | 0 | USD | 0001171843-22-001790 |
| FY 2020Yearly · 2020-12-31 | Product | Nonorthopedic | 8,060,000 | USD | 0001171843-22-001790 |
| FY 2020Yearly · 2020-12-31 | Product | OAPain Management | 83,029,000 | USD | 0001171843-22-001790 |
| FY 2019Yearly · 2019-12-31 | Geography | Europe | 14,744,000 | USD | 0001171843-22-001790 |
| FY 2019Yearly · 2019-12-31 | Geography | Other Location | 9,564,000 | USD | 0001171843-22-001790 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 90,302,000 | USD | 0001171843-22-001790 |
| FY 2019Yearly · 2019-12-31 | Product | Dermal | 2,244,000 | USD | 0001171843-20-001536 |
| FY 2019Yearly · 2019-12-31 | Product | Manufactured Product Other | 6,083,000 | USD | 0001171843-20-001536 |
| FY 2019Yearly · 2019-12-31 | Product | Orthobiologics | 101,002,000 | USD | 0001171843-20-001536 |
| FY 2019Yearly · 2019-12-31 | Product | Services | 98,000 | USD | 0001171843-20-001536 |
| FY 2019Yearly · 2019-12-31 | Product | Surgical | 5,183,000 | USD | 0001171843-20-001536 |
| FY 2018Yearly · 2018-12-31 | Geography | Europe | 11,730,000 | USD | 0001171843-21-001573 |
| FY 2018Yearly · 2018-12-31 | Geography | Other Location | 8,474,000 | USD | 0001171843-21-001573 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 85,351,000 | USD | 0001171843-21-001573 |
| FY 2018Yearly · 2018-12-31 | Product | Dermal | 396,000 | USD | 0001171843-19-001243 |
| FY 2018Yearly · 2018-12-31 | Product | Manufactured Product Other | 6,065,000 | USD | 0001171843-19-001243 |
| FY 2018Yearly · 2018-12-31 | Product | Milestone Revenue | 0 | USD | 0001171843-19-001243 |
| FY 2018Yearly · 2018-12-31 | Product | Orthobiologics | 93,556,000 | USD | 0001171843-19-001243 |
| FY 2018Yearly · 2018-12-31 | Product | Services | 24,000 | USD | 0001171843-19-001243 |
| FY 2018Yearly · 2018-12-31 | Product | Surgical | 5,514,000 | USD | 0001171843-19-001243 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.